These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17017577)

  • 21. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the start time of statin therapy for patients with diabetes.
    Denton BT; Kurt M; Shah ND; Bryant SC; Smith SA
    Med Decis Making; 2009; 29(3):351-67. PubMed ID: 19429836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins and cancer risk.
    Karp I; Behlouli H; Lelorier J; Pilote L
    Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins and heart failure.
    Athyros VG; Karagiannis A; Mikhailidis DP
    J Am Coll Cardiol; 2010 Apr; 55(15):1644-5; author reply 1646. PubMed ID: 20378087
    [No Abstract]   [Full Text] [Related]  

  • 26. Secondary prevention of stroke.
    Mascitelli L; Pezzetta F; Goldstein MR
    Lancet; 2008 Sep; 372(9643):1035; author reply 1036. PubMed ID: 18805325
    [No Abstract]   [Full Text] [Related]  

  • 27. Stroke and its prevention in chronic kidney disease.
    Khella S; Bleicher MB
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1343-51. PubMed ID: 17942760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal from statins: implications for secondary stroke prevention and acute treatment.
    Rodríguez-Yáñez M; Dávalos A; Castillo J
    Int J Stroke; 2008 May; 3(2):85-7. PubMed ID: 18706000
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statins in stroke prevention].
    Gedikli O; Baykan M
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
    Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invited commentary.
    Schaffer J; Singh SK
    Ann Thorac Surg; 2011 Mar; 91(3):660. PubMed ID: 21352974
    [No Abstract]   [Full Text] [Related]  

  • 33. C-reactive protein, stroke, and statins.
    Angerio AD; Bialko MF; White BM
    Crit Care Nurs Q; 2007; 30(2):161-5. PubMed ID: 17356357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paradox of cholesterol and stroke.
    Amarenco P; Steg PG
    Lancet; 2007 Dec; 370(9602):1803-4. PubMed ID: 18061038
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug insight: translating evidence on statin therapy into clinical benefits.
    Sanossian N; Ovbiagele B
    Nat Clin Pract Neurol; 2008 Jan; 4(1):43-9. PubMed ID: 18199996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins and pancreatic cancer risk: a nested case-control study.
    Bradley MC; Hughes CM; Cantwell MM; Murray LJ
    Cancer Causes Control; 2010 Dec; 21(12):2093-100. PubMed ID: 20697797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of aggressive statin therapy.
    Conn Med; 2005; 69(6):339-41. PubMed ID: 16184860
    [No Abstract]   [Full Text] [Related]  

  • 39. Statins and venous thromboembolism: a novel effect of statins?
    Paraskevas KI; Bessias N; Perdikides TP; Mikhailidis DP
    Curr Med Res Opin; 2009 Jul; 25(7):1807-9. PubMed ID: 19505206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.